Marcus Dasilva Goncalves MD PhD
Diabetes, Lipid Metabolism
Assistant Professor
Join to View Full Profile
222 E 41st Street23rd FloorNew York, NY 10016
Phone+1 212-481-1350
Dr. Goncalves is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Marcus Goncalves is an endocrinologist in New York, NY. He received his medical degree from the University of Pennsylvania and has been in practice 5 years. He specializes in muscle health, diabetes, low testosterone, and lipid metabolism.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2014 - 2018- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2012 - 2015
Perelman School of Medicine at the University of PennsylvaniaClass of 2012
Certifications & Licensure
NY State Medical License 2014 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- American Society of Clinical Investigation 2024
Publications & Presentations
PubMed
- Reply to: Overcoming Barriers to Cancer-Associated Cachexia Diagnosis and Management.Marcus D Goncalves, Tobias Janowitz
JCO Oncology Practice. 2025-03-13 - Early identification of weight loss trajectories in advanced cancer and associations with survival.Sophia Fuller, Stacey Alexeeff, Bette Caan, Marcus Dasilva Goncalves, Richard F Dunne
Journal of the National Cancer Institute. 2025-02-18 - Fueling metabolic disruption via FMD to boost chemotherapy in TNBC.Marcus D Goncalves, Neil M Iyengar
Cell Metabolism. 2025-02-04
Journal Articles
- Publisher Correction: Suppression of Insulin Feedback Enhances the Efficacy of PI3K InhibitorsSiddhartha Mukherjee, Marcus D Goncalves, Mark A Rubin, Nature
- Suppression of Insulin Feedback Enhances the Efficacy of PI3K InhibitorsMarcus D Goncalves, Siddhartha Mukherjee, Mark A Rubin, Nature
Press Mentions
Earlier Identification of Cachexia in Advanced Cancer PossibleFebruary 18th, 2025- Skye Bioscience to Host Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” on July 24thJuly 11th, 2024
Colon Cancer Risk High with High Fructose Corn Syrup ConsumptionApril 14th, 2019- Join now to see all
Grant Support
- Combination Therapies Targeting Insulin Signaling in Endometrial CancerNEW YORK UNIVERSITY SCHOOL OF MEDICINE2024–2028
- The role of PKM2 in dietary lipid absorption and fructose-induced obesityWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell SurvivalNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
- Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell SurvivalNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
- The CANcer Cachexia Action Network (CANCAN): a Multidisciplinary Virtual Institute with the Mission to Cure Cancer CachexiaNEW YORK UNIVERSITY SCHOOL OF MEDICINE2024–2025
- The CANcer Cachexia Action Network (CANCAN): a Multidisciplinary Virtual Institute with the Mission to Cure Cancer CachexiaNEW YORK UNIVERSITY SCHOOL OF MEDICINE2024–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
